EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The Impact of the Mediterranean Diet and Lifestyle Intervention on Lipoprotein Subclass Profiles among Metabolic Syndrome Patients: Findings of a Randomized Controlled Trial

Beatriz Candás-Estébanez, Bárbara Fernández-Cidón iD, Emili Corbella iD, Cristian Tebé, Marta Fanlo-Maresma iD, Virginia Esteve-Luque iD, Jordi Salas-Salvadó iD, Montserrat Fitó, Antoni Riera-Mestre iD, Emilio Ros iD, Xavier Pintó iD

International Journal of Molecular Sciences · 22.01.2024 · 25 (2) · 1338

DOI: 10.3390/ijms25021338 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.01.2024. Verfasst von Beatriz Candás-Estébanez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain. Hauptthemen laut MEDLINE: Metabolic Syndrome, Diet, Mediterranean. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital Universitari de Bellvitge research grant (Institut Català de la Salut), Department of Biochemistry, Molecular Biology and Biomedicine, Autonomous University of Barcelona (UAB), Barcelona, Spain, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic syndrome (MetS) is associated with alterations of lipoprotein structure and function that can be characterized with advanced lipoprotein testing (ADLT). The effect of the Mediterranean diet (MedDiet) and weight loss on the lipoprotein subclass profile has been scarcely studied. Within the PREDIMED-Plus randomized controlled trial, a sub-study conducted at Bellvitge Hospital recruiting center evaluated the effects of a weight loss program based on an energy-reduced MedDiet (er-MedDiet) and physical activity (PA) promotion (intervention group) compared with energy-unrestricted MedDiet recommendations (control group) on ADLT-assessed lipoprotein subclasses. 202 patients with MetS (n = 107, intervention; n = 95, control) were included. Lipid profiles were determined, and ADLT was performed at baseline, 6, and 12 months. Linear mixed models were used to assess the effects of intervention on lipoprotein profiles. Compared to the control diet, at 12 months, the er-MedDiet+PA resulted in a significant additional 4.2 kg of body weight loss, a decrease in body mass index by 1.4 kg/m2, reduction in waist circumference by 2.2 cm, decreased triglycerides, LDL-cholesterol and non-HDL-cholesterol, and increased HDL-cholesterol. In er-MedDiet+PA participants, ADLT revealed a decrease in small dense-LDL-cholesterol (sd-LDL-C), intermediate-density lipoproteins, VLDL-triglyceride, and HDL-Triglyceride, and an increase in large LDL and large VLDL particles. In conclusion, compared to an ad libitum MedDiet (control group), er-MedDiet+PA decreased plasma triglycerides and the triglyceride content in HDL and VLDL particles, decreased sd-LDL-C, and increased large LDL particles, indicating beneficial changes against cardiovascular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeDiet, MediterraneanHumansCholesterol, LDLLipoproteinsTriglyceridesCholesterolLife Style

Stichwörter der Autor:innen

Mediterranean dietadvanced lipoprotein testslipoprotein precipitationmetabolic syndromenuclear magnetic resonance lipid profilesmall dense LDL

Substanzen

Cholesterol, LDLLipoproteinsTriglyceridesCholesterol

Autor:innen und Institutionen

  • Clinical Laboratory, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.
  • Clinical Laboratory, SCIAS-Barcelona Hospital, 08036 Barcelona, Spain.
  • Department of Biochemistry, Molecular Biology and Biomedicine, Autonomous University of Barcelona (UAB), 08193 Barcelona, Spain.
  • Lipids and Vascular Risk Unit, Internal Medicine Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.
  • Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.
  • Center for Biomedical Research in Obesity and Nutrition Physiopathology Network (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.

ORCID-Profile: Bárbara Fernández-Cidón, Emili Corbella, Marta Fanlo-Maresma, Virginia Esteve-Luque, Jordi Salas-Salvadó, Antoni Riera-Mestre, Emilio Ros, Xavier Pintó

Förderung

  • Hospital Universitari de Bellvitge research grant (Institut Català de la Salut)
  • Department of Biochemistry, Molecular Biology and Biomedicine, Autonomous University of Barcelona (UAB), Barcelona, Spain
  • Instituto de Salud Carlos III
  • Spanish Ministry of Health (Carlos III Health Institute)
  • European Regional Development Fund
  • ICREA (Catalan Institution for Research and Advanced Studies)

Zitieren

APA

Candás-Estébanez, B., Fernández-Cidón, B., Corbella, E., Tebé, C., Fanlo-Maresma, M., Esteve-Luque, V., Salas-Salvadó, J., Fitó, M., Riera-Mestre, A., Ros, E., & Pintó, X. (2024). The Impact of the Mediterranean Diet and Lifestyle Intervention on Lipoprotein Subclass Profiles among Metabolic Syndrome Patients: Findings of a Randomized Controlled Trial. International Journal of Molecular Sciences, 25(2), 1338. https://doi.org/10.3390/ijms25021338

Vancouver

Candás-Estébanez B, Fernández-Cidón B, Corbella E, Tebé C, Fanlo-Maresma M, Esteve-Luque V, et al. The Impact of the Mediterranean Diet and Lifestyle Intervention on Lipoprotein Subclass Profiles among Metabolic Syndrome Patients: Findings of a Randomized Controlled Trial. International Journal of Molecular Sciences. 2024;25(2):1338. doi:10.3390/ijms25021338

BibTeX
@article{CandsEstbanez2024,
  author = {Candás-Estébanez, Beatriz and Fernández-Cidón, Bárbara and Corbella, Emili and Tebé, Cristian and Fanlo-Maresma, Marta and Esteve-Luque, Virginia and Salas-Salvadó, Jordi and Fitó, Montserrat and Riera-Mestre, Antoni and Ros, Emilio and Pintó, Xavier},
  title = {The Impact of the Mediterranean Diet and Lifestyle Intervention on Lipoprotein Subclass Profiles among Metabolic Syndrome Patients: Findings of a Randomized Controlled Trial},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {2},
  pages = {1338},
  doi = {10.3390/ijms25021338}
}
Kostenlos starten →